Dr. Wing Chan is currently serving as Chief Medical Services Officer at HSBC Life, leading the end-to-end medical engagement and insurance fulfillment capability including medical partnerships and network management, claims operations and Insights to drive insurance business. Through building automation and analytics capabilities, and anchoring in customer centricity, Dr. Chan drives operational, technological and cultural transformation of HSBC from a claim-paying insurer to a holistic health and wellness partner and offers seamless value adding services that cater to the core needs of our customers. Prior to her current role, Dr. Chan was the Chief Medical Affairs at HSBC Life since 2019.

Prior to her appointment at HSBC Life, Dr. Chan served as the Chief Pharmacist & Medical Affairs at a digital health company where she oversee the clinical R&D efforts. Among other products, she led the clinical research & development efforts for the HSBC ONEdna and ONEdna+ offering.

Dr. Chan brings significant experiences from both research academic as well as in clinical settings, having been a clinical pharmacist in the US before relocating to Hong Kong SAR in 2015. Dr. Chan was deeply involved in clinical and translational research including pharmacogenomics, health predispositions, common hereditary cancers and Mendelian diseases etc. Her research focused on the use of cutting-edge technologies such as next generation sequencing and their applications in clinical practice. Dr. Chan received her Dr. of Pharmacy with summa cum laude from the University of Minnesota, and a Master in Business Administration degree from The University of Chicago Booth School of Business, USA.

Prof Timothy Kwok graduated from University of Leicester in the UK and received specialist training in Geriatric and Internal Medicine in St George’s Hospital in London before returning to Hong Kong, to join the Department of Medicine & Therapeutics in the Chinese University of Hong Kong (CUHK) in 1994. He obtained his MD in 2004. He was promoted to professorship in 2006, and was endowed SC Ho Professorship in 2022. At CUHK, he is director of Jockey Club Centre for Positive Ageing (a comprehensive care centre for people with dementia), Jockey Club centre for osteoporosis care and control and Asia Pacific Institute of healthy ageing. His research interests include dementia, B vitamins for brain health, osteoporosis, falls, nutrition in older people.

Dr. LIU Xing obtained his Ph.D. in Biochemistry from The Chinese University of Hong Kong. After that, he engaged in the technology and testing industry. In 2017, he joined BGI Group, a world-leading institution in life science, and is committed to providing affordable precision medicine and public health solutions for local society. In 2022, he was awarded the Chief Executive's Commendation for Community Service of the Hong Kong Special Administrative Region for his contributions during the epidemic. He is a Member of Chongqing Youth Federation. He serves as panelist of Expert Review Panel of Logistics and Supply Chain MultiTech R&D Centre and public adviser of Panel of Film Censorship Advisers.

Lijing L. Yan, PhD, MPH, Professor (with tenure) of Global Health and Head of Non-communicable Chronic Diseases (NCDs) Research at the Global Health Research Center, and Director of the Implementation Research on NCD Management Laboratory (IRoNman Lab), Duke Kunshan University. She is also currently adjunct professor at Peking University Institute for Global Health and Development; School of Public Health, Wuhan University; Duke Global Health Institute, Duke University, USA; and the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Previously, she was the Director of Graduate Studies for the Master of Science in Global Health Program at Duke Kunshan University, the Deputy Director of the George Institute for Global Health at Peking University Health Science Center, and Director of the China International Center for Chronic Disease Prevention, a large network of 5 international academic institutions and 7 Chinese institutions dedicated to combat NCDs in China. She is the former secretary general of the China Consortium of Universities for Global Health, and the current standing council member of the Global Health Society and the NCD Prevention and Control Society of the Chinese Preventive Medicine Association. She has a bachelor’s degree in Sociology from Peking University, a Master of Public Health degree in Epidemiology and a doctoral degree in Demography from the University of California, Berkeley. Her main areas of research are primary-care and community-based chronic disease prevention and control (hypertension, stroke, heart disease, and diabetes in particular), healthy aging, digital health innovation and implementation science. She is the Principal Investigator or Co-Investigator on over 20 US NIH and UK MRC-funded and China-funded research grants, totaling over 10 million US dollars. She has published over 200 peer-reviewed scientific papers some of which in leading medical journals such as JAMA, the Lancet, NEJM, BMJ, and Circulation. Her Google Scholar H-index is 60 and i10-index 132, total citations over 87,000 (as of March 2025). She also provides advice and consultancy to national and international organizations such as the China National Health Commission and World Health Organization.

Professor Peter P. Yuen is Dean of the College of Professional and Continuing Education (CPCE) of The Hong Kong Polytechnic University (PolyU). He is also Professor in the Department of Management and Marketing of PolyU. He received his Bachelor of Arts degree in Cellular and Molecular Biology and Master in Business Administration degree from the State University of New York at Buffalo, and his Doctor of Philosophy degree in Health Economics from the University of Birmingham. He is a founding Fellow of the Hong Kong College of Health Services Executives, and an Honorary Fellow of the Australian College of Health Services Management. Professor Yuen’s research involves public policy formulation and evaluation, and health services management. He is also the Co-Editor-in-Chief of Public Administration and Policy, an Editorial Committee member of Asia Pacific Journal of Health Management.

Professor Wong is a scholar and specialist in Family Medicine, and a researcher in the field of cancer screening and prevention of chronic diseases. He is currently a Professor and Director of the Centre for Health Education and Health Promotion, Faculty of Medicine, the Chinese University of Hong Kong. He is also the Associate Head and Dean of Students of the United College, CUHK. He has over 600 publications in international peer-reviewed journals, and has received over 15 international and local research awards for his studies. His expertise of “Colorectal Neoplasm”, “Mass Screening”, “Early Detection of Cancer” ranks in the top 0.055%, 0.095%, and 0.14% in the world, respectively. He ranks as the top number 1 researcher in China in the field of disease screening [from expertscape: https://www.expertscape.com/; on 10/9/2022]. He is a leader of an international research group which is a global organization jointly participated by various Universities in the world. He has been co-chairman of the APRU Global Programme [NCD] for many years. In 2024, he was selected as a “Highly Cited Researcher” by Clarivate, an award which recognizes awardees as the pioneer in his field over the last decade, demonstrating significant and broad influence in one’s field of research.